SonarMD, LLC

SonarMD, LLC is a digital health company focused on managing the health of patients with inflammatory bowel disease (IBD) through a comprehensive monitoring platform that emphasizes early intervention and improved patient outcomes. Founded in 2015 and headquartered in Elgin, US, SonarMD, LLC specializes in providing a digital platform for monitoring patients with inflammatory bowel disease. The company has undergone no significant pivots in its strategy. The founder, Lawrence Kosinski, has a background in healthcare technology, although details of previous ventures are not available.

SonarMD raised USD 10. 5 mn in its Series A funding round on December 17, 2018, from investors Arboretum Ventures and BlueCross BlueShield Venture Partners. The total amount raised by the company stands at USD 10. 5 mn.

SonarMD offers a comprehensive digital platform designed to monitor and manage the health of patients with inflammatory bowel disease (IBD), focusing on conditions such as Crohn's disease and ulcerative colitis. The core service involves a monthly health assessment delivered through secure email or text, based on validated clinical surveys like the Crohn’s Disease Activity Index and Ulcerative Colitis Disease Activity Index. This assessment generates a personalized Sonar Score that reflects the patient’s health status without the patient directly viewing the score. SonarMD actively collaborates with healthcare providers and health plans to facilitate early intervention for patients experiencing symptoms of clinical decline, thereby improving patient outcomes and reducing healthcare costs.

The platform is designed for use in the United States, specifically targeting practices that treat chronic gastrointestinal conditions and their patient populations. SonarMD's revenue model is structured around partnerships with healthcare providers and health plans, focusing on a value-based care approach. Through these partnerships, practices receive a share of savings achieved by utilizing SonarMD’s monitoring system, which includes a prepayment on shared savings distributed as a per member, per quarter fee. This financial structure allows providers to maintain their traditional fee-for-service reimbursement while benefiting from additional income generated through SonarMD's services.

The firm’s engagement with practices is intended to enhance patient care management, leading to increased office visits and reduced emergency room visits. SonarMD does not charge patients for access to its platform, thus ensuring that its services are accessible to end-users while driving revenue through its partnerships within the healthcare ecosystem. In the upcoming months, SonarMD plans to enhance its platform with new product offerings aimed at improving patient engagement and monitoring capabilities. The company is also targeting expansions into additional markets across the United States to reach a broader patient population.

The recent Series A funding of USD 10. 5 mn will support these initiatives, enabling SonarMD to reinforce its technological infrastructure and broaden its partnerships with healthcare organizations.